Annual Family Premiums for Employer Coverage Rise 6% in 2025, Nearing $27,000, with Workers Paying $6,850 Toward Premiums Out of Their Paychecks

Employer-sponsored family health insurance premiums are projected to rise 6% to nearly $27,000 in 2025, with workers contributing an average of $6,850, significantly outpacing general inflation and wage growth. This escalation is largely attributed to increasing prescription drug prices, particularly GLP-1s for weight loss, and hospital costs. While more large firms are now covering GLP-1s, many report that these costs have exceeded expectations, prompting potential coverage restrictions or re-evaluation. Anticipating further sharp increases, employers are struggling to manage these rising expenses, which is expected to lead to higher deductibles and increased employee cost-sharing, impacting corporate benefits strategies and the broader healthcare sector.

Analysis

Employer-sponsored family health insurance premiums are projected to increase by 6% to an average of $26,993 in 2025, with workers contributing $6,850 annually. This rise significantly outpaces general inflation at 2.7% and wage growth at 4%, indicating growing cost pressures on both employers and employees. Key drivers include prescription drug prices, cited by 36% of large firms as a "great deal" contributor, alongside hospital prices and chronic disease prevalence.

The increasing adoption and cost of GLP-1 drugs for weight loss are a significant factor, with 43% of the largest firms now covering them, up from 28% in 2024. However, 59% of these employers report that GLP-1 costs have exceeded expectations, and 66% note a "significant" impact on drug spending. This financial strain is prompting employers to consider tighter utilization controls, restrictions, or even elimination of coverage, with only 1% of non-offering firms likely to add coverage next year.

KFF President Drew Altman anticipates sharper premium increases next year, driven by GLP-1s and hospital prices, as employers lack effective cost-control mechanisms. This is expected to result in higher deductibles and increased employee cost-sharing, a strategy neither employers nor employees favor but is resorted to under pressure. The average single deductible has already risen to $1,886, up 17% since 2020, with small firms facing significantly higher deductibles at $2,631.

Key Decisions for Investors

• Monitor healthcare sector companies, particularly pharmaceutical firms with high-cost drugs like GLP-1s and hospital groups, for sustained revenue growth tempered by potential employer-imposed coverage restrictions.
• Factor rising employer healthcare costs into corporate earnings models, as the 6% premium increase will pressure corporate profitability and potentially influence labor cost management strategies.
• Evaluate health insurance and benefits administration providers for their ability to manage escalating claims costs and offer effective cost-containment solutions to employers.
• Assess the impact of increased employee cost-sharing (higher premiums and deductibles) on consumer discretionary spending and broader economic growth, especially for sectors reliant on middle-income consumers.